The General Hospital Corporation, et al v. Esoterix Genetic Laboratories, LLC
LABORATORY CORPORATION OF AMERICA HOLDINGS, a/k/a Laboratory Corporation of America |
QIAGEN MANCHESTER, LTD. and QIAGEN, INC. |
ESOTERIX GENETIC LABORATORIES, LLC |
DANA-FARBER CANCER INSTITUTE and GENERAL HOSPITAL CORP. |
20-2126 |
November 30, 2020 |
U.S. Court of Appeals, First Circuit |
Other |
Opinions
We have the following opinions for this case:
Description |
---|
General Hospital Corp. v. Esoterix Genetic Laboratories, LLC |
Docket Report
This docket was last retrieved on January 8, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
NOTICE of appearance on behalf of Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC and Appellee Laboratory Corporation of America Holdings in 20-2126, 20-2149 filed by Attorney Christopher R. Howe. Certificate of service dated 01/08/2021. [20-2126, 20-2149] (CRH) [Entered: 01/08/2021 01:49 PM] |
NOTICE of appearance on behalf of Appellees/Cross-Appellants General Hospital Corp. and Dana-Farber Cancer Institute in 20-2149, 20-2126 filed by Attorney Douglas J. Nash. Certificate of service dated 01/07/2021. [20-2149, 20-2126] (DJN) [Entered: 01/07/2021 03:47 PM] |
NOTICE issued. The following attorney has failed to register for an appellate ECF account and will no longer receive notice of court issued documents in this case: Douglas J. Nash for Dana-Farber Cancer Institute and General Hospital Corp.. [20-2126] (GB) [Entered: 12/30/2020 08:04 AM] |
CROSS-APPEAL briefing schedule set pursuant to F.R.A.P. 28.1. Brief and Appendix due 02/01/2021 for appellant Esoterix Genetic Laboratories, LLC. Please see the court's general order issued April 20, 2020, requiring the electronic filing of appendices. [20-2126, 20-2149] (GB) [Entered: 12/22/2020 08:44 AM] |
DISCLOSURE statement filed by Appellee/Cross-Appellant Dana-Farber Cancer Institute in 20-2126, 20-2149. Certificate of service dated 12/22/2020. [20-2126, 20-2149] CLERK'S NOTE: Party selection was incomplete. Correction made by clerk's office. No further action required. (CMC) [Entered: 12/22/2020 10:16 AM] |
DISCLOSURE statement filed by Appellee/Cross-Appellant General Hospital Corp. in 20-2126, 20-2149. Certificate of service dated 12/22/2020. [20-2126, 20-2149] CLERK'S NOTE: Party selection was incomplete. Correction made by clerk's office. No further action required. (CMC) [Entered: 12/22/2020 10:18 AM] |
TRANSCRIPT report/order form filed by Appellees/Cross-Appellants Dana-Farber Cancer Institute and General Hospital Corp. indicating all necessary transcripts have already been filed in district court. Certificate of service dated 12/21/2020. [20-2126] CLERK'S NOTE: The document should have been filed in cross-appeal case no 20-2149 ONLY, not 20-2126. THE FILER IS DIRECTED TO RE-FILE THE DOCUMENT WITHIN TWO DAYS, BY 12/23/2020. (CMC) [Entered: 12/21/2020 12:46 PM] |
DOCKETING statement filed by Appellees/Cross-Appellants Dana-Farber Cancer Institute and General Hospital Corp.. Certificate of service dated 12/21/2020. [20-2126] CLERK'S NOTE: The document should have been filed in cross-appeal case no 20-2149 ONLY, not 20-2126. THE FILER IS DIRECTED TO RE-FILE THE DOCUMENT WITHIN TWO DAYS, BY 12/23/2020. (CMC) [Entered: 12/21/2020 12:42 PM] |
NOTICE of appearance on behalf of Appellees/Cross-Appellants Dana-Farber Cancer Institute and General Hospital Corp. filed by Attorney Carolyn M. Crowley. Certificate of service dated 12/21/2020. [20-2126] CLERK'S NOTE: The document should have been filed in cross-appeal case no 20-2149 ONLY, not 20-2126. THE FILER IS DIRECTED TO RE-FILE THE DOCUMENT WITHIN TWO DAYS, BY 12/23/2020. (CMC) [Entered: 12/21/2020 12:35 PM] |
NOTICE issued. After 12/29/2020, the following attorney will no longer receive notice of court issued documents in this case unless he registers for an appellate ECF account: Douglas J. Nash for Dana-Farber Cancer Institute and General Hospital Corp.. [20-2126] (GB) [Entered: 12/15/2020 06:56 AM] |
NOTICE of appearance on behalf of Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC and Appellee Laboratory Corporation of America Holdings filed by Attorney Jaclyn M. Metzinger. Certificate of service dated 12/09/2020. [20-2126] (JM) [Entered: 12/09/2020 04:00 PM] |
DOCKETING statement filed by Appellee Laboratory Corporation of America Holdings and Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC. Certificate of service dated 12/09/2020. [20-2126] (JM) [Entered: 12/09/2020 04:03 PM] |
TRANSCRIPT report/order form filed by Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC and Appellee Laboratory Corporation of America Holdings indicating all necessary transcripts have already been filed in district court. Certificate of service dated 12/09/2020. [20-2126] (JM) [Entered: 12/09/2020 04:07 PM] |
NOTICE of appearance on behalf of Appellant/Cross-Appellee Esoterix Genetic Laboratories, LLC and Appellee Laboratory Corporation of America Holdings filed by Attorney Robert I. Steiner. Certificate of service dated 12/09/2020. [20-2126] (RIS) [Entered: 12/09/2020 04:15 PM] |
ORDER directing the parties to proceed under F.R.A.P 28.1. The parties have filed cross-appeals in No. 1:18-cv-11360-IT (D. Mass.). Pursuant to Fed. R. App. P. 28.1, it is hereby ordered that defendant Esoterix Genetic Laboratories, LLC be deemed the appellant/cross-appellee (appellant) and that plaintiffs The General Hospital Corporation and Dana-Farber Cancer Institute, Inc. be deemed the appellees/cross-appellants (appellees). Defendant Laboratory Corporation of America Holdings is deemed a cross-appellee only. The parties are directed to use the above caption on all future filings related to these cases. A briefing schedule will be set once the record on appeal, including all necessary transcripts, is complete. The attached information sheet sets forth the filing requirements for briefs filed pursuant to Fed. R. App. P. 28.1. [20-2126, 20-2149] (GB) [Entered: 12/08/2020 09:27 AM] |
CIVIL CASE docketed. Notice of appeal (doc. #155) filed by Appellant Esoterix Genetic Laboratories, LLC. Appearance form, Docketing Statement and Transcript Report/Order form due 12/14/2020 . [20-2126] (GB) [Entered: 11/30/2020 01:37 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.